Immunoglobulin G (IgG) Subtype Is Associated with a Favorable Survival Prognosis in Patients Irradiated for Spinal Cord Compression from Myeloma

Dirk Rades, Antonio J. Conde-Moreno, Niklas Gebauer, Tobias Bartscht, Jon Cacicedo, Barbara Segedin, Steven E. Schild

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

AIM: This study was performed to investigate the prognostic impact of the myeloma subtype on the survival prognosis of patients with spinal cord compression (SCC) from myeloma.

PATIENTS AND METHODS: In 238 patients irradiated for SCC from myeloma, the myeloma subtype and 10 additional characteristics were evaluated for survival. These characteristics were fractionation of radiotherapy, age, time from myeloma diagnosis to SCC, presence of extra-osseous lesions, additional osseous lesions, gender, time to developing motor weakness, ability to walk, number of vertebrae affected by SCC and performance status.

RESULTS: Immunoglobulin G subtype was associated with significantly better survival than other subtypes both at 1 year (80% vs. 50%) and at 2 years (56% vs. 30%) following radiotherapy of SCC (p

CONCLUSION: This study identified myeloma subtype as being an independent prognostic factor of survival in patients with SCC from myeloma.

Original languageEnglish (US)
Pages (from-to)375-378
Number of pages4
JournalAnticancer Research
Volume36
Issue number1
StatePublished - Jan 1 2016

Keywords

  • Immunoglobulin G
  • myeloma
  • radiotherapy
  • spinal cord compression
  • survival

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Immunoglobulin G (IgG) Subtype Is Associated with a Favorable Survival Prognosis in Patients Irradiated for Spinal Cord Compression from Myeloma'. Together they form a unique fingerprint.

  • Cite this

    Rades, D., Conde-Moreno, A. J., Gebauer, N., Bartscht, T., Cacicedo, J., Segedin, B., & Schild, S. E. (2016). Immunoglobulin G (IgG) Subtype Is Associated with a Favorable Survival Prognosis in Patients Irradiated for Spinal Cord Compression from Myeloma. Anticancer Research, 36(1), 375-378.